Pharmafile Logo
Pharmafocus logo
Advanced Search

Belharra Therapeutics and Genentech join forces for small molecule medicine development

January 5, 2023
Research and Development

US-based biotech companies Belharra Therapeutics and Genentech have announced a multi-year partnership to lead the discovery and development of small …

News

Biogen and Alcyone Therapeutics enter partnership to develop ThecaFlex DRx system for ASO therapies

January 5, 2023
Research and Development

US-based Biogen and Alcyone Therapeutics have entered into a license and collaboration agreement to develop Alcyone’s ThecaFlex DRx™ System.   …

News

Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program

January 4, 2023
Business Services

Amsterdam and San Francisco / Houston / Singapore, 4 January 2023 — Synaffix B.V.

News
Press release

ISA Pharmaceuticals and Cancer Focus Fund Announce $5 Million Investment to Support First-in-Human Trial of ISA’s Novel Immunotherapy ISA103 in Uveal Melanoma

January 4, 2023
Business Services

Oegstgeest, Netherlands and Houston, Texas, January 4, 2023 – ISA Pharmaceuticals, B.V., a clinical stage biotech company developing immunotherapies to …

News
Press release

Dr Samson Fung

January 4, 2023
Business Services

Molecure Appoints Dr. Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing …

Appointment

Actimed Therapeutics successfully closes second tranche of £10m seed financing to progress pipeline for treatment of cancer cachexia and other muscle wasting disorders

January 4, 2023
Business Services

London, UK – 4 January 2023. Actimed Therapeutics Ltd, a UK based clinical stage specialty pharmaceutical company focused on bringing …

News
Press release

FDA expands access to abortion pills

January 4, 2023
Medical Communications

Following new rules from the FDA under the Biden administration, patients can now obtain the abortion pill mifepristone from retail …

News

Novartis pays $245m to settle Exforge generic pay-for-delay lawsuit

January 4, 2023
Medical Communications

Swiss pharma company Novartis will settle a classic generic pay-for-delay legal battle with direct purchasers, indirect purchasers and retailers regarding …

News

FDA grants Breakthrough Device Designation for Burning Rock’s multi-cancer detecting test

January 4, 2023
Medical Communications

Burning Rock, a Chinese biotech company which focuses on the applications of next-generation sequencing (NGS) technology in the field of …

News

FDA expected to make decision on controversial Alzheimer’s drug this week

January 4, 2023
Medical Communications

The FDA are expected to come to a decision on Eisai and Biogen’s Alzheimer’s drug lecanemab by the end of …

News

Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

January 3, 2023
Business Services

Milan, Italy, Jan. 3, 2023, 07:00 am CET – Newron Pharmaceuticals S.p.A.

News
Press release

Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

January 3, 2023
Business Services

BEERSE, BELGIUM, 3 January 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a …

News
Press release

Cost of over 350 drugs expected to increase in 2023

January 3, 2023
Sales and Marketing

With many pharma companies preparing for President Joe Biden’s Inflation Reduction Act (IRA) to begin having an impact, and inflation …

News

Rare cancer drug for young patients approved

January 3, 2023
Research and Development

A new treatment option for adult and paediatric patients with a rare soft tissue cancer has been approved. The FDA …

News

MediWound receives FDA approval for NexoBrid

January 3, 2023
Medical Communications

Israeli biopharma company MediWound has secured FDA approval for its wound care product NexoBrid (anacaulase-bcdb). US-based biopharma company Vericel will …

News

Datar blood test receives FDA Breakthrough Designation

January 3, 2023
Medical Communications

Datar Cancer Genetics has secured FDA Breakthrough Designation for their blood test used to detect inaccessible brain tumours, where traditional …

News

BioNTech begins phase 1 trial for malaria vaccine

December 23, 2022
Medical Communications

BioNTech has announced the start of its new first-in-human phase 1 trial for BNT165b1, a candidate from its programme which …

News

Celltrion submits application for CT-P13 SC to FDA

December 23, 2022
Medical Communications

Celltrion has announced that it has finalised its submission of a biologics license application for the subcutaneous version of a …

News

Moderna signs ten-year deal with UK Government for vaccine production

December 23, 2022
Manufacturing and Production

US biotech company Moderna has finalised a partnership with the UK government to produce vaccines, the main element of which …

News

COVID-19 antiviral treatment shown to speed up recovery in trial

December 23, 2022
Medical Communications

Molnupiravir, made by Merck, Sharp and Dohme (MSD), has been found to reduce the recovery time of COVID-19 patients, however …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025